Clinical Pharmacology

The study of how medications affect biological processes and how the body reacts to pharmaceuticals is known as pharmacology. The sources, chemical make-up, biological effects, and therapeutic applications of medications are all covered by the study of pharmacology.

The connection between preclinical data and novel patient treatments is made possible by clinical pharmacology. Whether it’s a first-in-human study, a biomarker exploration study, or a study required for your NDA submission, the scientists and physicians at CliniMed LifeSciences thoroughly assess the safety, tolerability, and pharmacokinetics of the medicine. We offer the solutions you require to decide the optimum course for your medication development journey.

Let us assist you in handling complexity. Our integrated drug development platform is designed to manage a variety of research types, including multisite hybrid studies, rapid dose escalations, complex biomarker or imaging exploratory endpoints, extemporaneous investigational product production, and more. Additionally, we never lose sight of the two crucial focal areas of scientific integrity and subject safety as we oversee the conduct of your intricate investigation.

You require a worldwide partner who can develop your clinical pharmacology studies for biologics and small compounds. Together, we’ll develop solid protocols for Phase I safety, signs of target engagement, and pharmacodynamics in healthy people and patients using the safety data from your preclinical studies.

The link between preclinical data and the intended audience is clinical pharmacology. Our team of scientists and physicians continuously monitors testing, including initial evaluation of drug safety, tolerance, and pharmacokinetics, in order to put concepts into practice. We’ll examine development progress when new details about your molecule become available and provide insightful analysis to help you make decisions.

Expertise in difficult, specialized, and conventional research can mean the difference between working with one partner and managing numerous vendors as your medicine nears registration. At four locations in the U.S. and the U.K., you will have access to more than 316 beds. We provide a full range of pharmacology services to manage every stage of your early clinical development as one of the largest early-stage clinical research firms in the world.

It helps to have a partner with strong hospital partnerships when you conduct an increasing number of clinical Phase I studies in patient groups. We are able to undertake high-quality first-in-human early clinical research in a regulated setting by working with hospitals close to our clinical research sites.